Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Aug-21 7:39 PM View:  | Travere Therapeutics, Inc. (TVTX) | 17-Aug-21 | Market Sale | 1,407 | $17.12 | $24,085.00 | (3%) 49.02K to 47.61K | |
| 17-Aug-21 7:39 PM View: | Travere Therapeutics, Inc. (TVTX) | 13-Aug-21 | Grant | 4,500 | -- | -- | 10% 44.52K to 49.02K | |
| 29-Jul-21 4:09 PM View: | Travere Therapeutics, Inc. (TVTX) | 28-Jul-21 | Market Sale (Planned) | 1,250 | $13.81 | $17,262.50 | (3%) 45.77K to 44.52K | (2%) |
| 13-May-21 4:11 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-May-21 | Market Sale (Planned) | 375 | $19.46 | $7,297.50 | (< 1%) 45.97K to 45.59K | < 1% |
| 13-May-21 4:11 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-21 | Market Sale (Planned) | 375 | $19.14 | $7,177.50 | (< 1%) 46.34K to 45.97K | (4%) |
| 09-Feb-21 4:32 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-Feb-21 | Market Sale (Planned) | 1,125 | $31.58 | $35,527.50 | (2%) 47.47K to 46.34K | 2% |
| 09-Feb-21 4:32 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Feb-21 | Market Sale (Planned) | 1,125 | $31.41 | $35,336.20 | (2%) 48.59K to 47.47K | (1%) |
| 05-Feb-21 4:49 PM View: | Travere Therapeutics, Inc. (TVTX) | 03-Feb-21 | Grant | 4,500 | -- | -- | 10% 44.09K to 48.59K | |
| 03-Feb-21 9:33 PM View: | Travere Therapeutics, Inc. (TVTX) | 03-Feb-21 | Market Sale (Planned) | 1,813 | $28.91 | $52,413.80 | (4%) 45.91K to 44.09K | (5%) |
| 02-Feb-21 9:31 PM View: | Travere Therapeutics, Inc. (TVTX) | 02-Feb-21 | Market Sale (Planned) | 1,813 | $30.75 | $55,749.80 | (4%) 47.72K to 45.91K | |
| 02-Feb-21 9:31 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-21 | Grant | 5,000 | -- | -- | 12% 42.72K to 47.72K | |
| 25-Jan-21 8:57 PM View: | Travere Therapeutics, Inc. (TVTX) | 21-Jan-21 | Grant | 15,000 | -- | -- | 54% 27.72K to 42.72K | |
| 23-Sep-20 8:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 23-Sep-20 | Market Sale (Planned) | 750 | $18.48 | $13,860.00 | (3%) 28.3K to 27.55K | (5%) |
| 22-Sep-20 9:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 22-Sep-20 | Market Sale (Planned) | 750 | $18.59 | $13,942.50 | (3%) 29.05K to 28.3K | |
| 22-Sep-20 9:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 18-Sep-20 | Grant | 3,000 | -- | -- | 12% 26.05K to 29.05K | |
| 30-Jul-20 7:48 PM View: | Travere Therapeutics, Inc. (TVTX) | 28-Jul-20 | Market Sale | 870 | $20.49 | $17,826.30 | (3%) 26.93K to 26.05K | |
| 13-May-20 9:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-May-20 | Market Sale | 527 | $16.98 | $8,950.73 | (2%) 27.25K to 26.73K | |
| 09-Mar-20 9:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Mar-20 | Grant | 5,000 | -- | -- | 21% 24.05K to 29.05K | |
| 09-Mar-20 9:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Mar-20 | Market Sale | 1,790 | $15.36 | $27,487.20 | (6%) 29.05K to 27.25K | |
| 31-Jan-20 8:18 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-20 | Grant | 9,000 | -- | -- | 67% 13.5K to 22.5K | |
| 31-Jul-19 9:15 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jul-19 | Market Sale (Planned) | 1,250 | $20.07 | $25,087.50 | (8%) 14.75K to 13.5K | 3% |
| 31-Jul-19 9:15 PM View: | Travere Therapeutics, Inc. (TVTX) | 30-Jul-19 | Market Sale (Planned) | 1,250 | $19.82 | $24,775.00 | (8%) 16.0K to 14.75K | 2% |
| 10-May-19 9:41 PM View: | Travere Therapeutics, Inc. (TVTX) | 09-May-19 | Grant | 6,000 | -- | -- | 60% 10.0K to 16.0K | |
| 30-Jul-18 8:08 PM View: | Travere Therapeutics, Inc. (TVTX) | 26-Jul-18 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K |